ARCHIVE
Investigating the drug−drug interactions occurring in cancer-associated thrombosis: use of checkpoint inhibitors and direct oral anticoagulants in a real-world setting
Advances in medicine and the possibility of keeping multiple diseases under control via medication have increased the...
UPDATE: 10th International Conference on Thrombosis and Hemostasis Issues in Cancer
The 10th International Conference on Thrombosis and Hemostasis Issues in Cancer (ICTHIC) will go virtual....
The USCAT study: a retrospective non-interventional study to examine long-term treatment of CAT
Patients with cancer are at high risk of venous thromboembolism (VTE) recurrence and major bleeding (1). Most...
Webinar: cancer-associated thrombosis – updates and controversies
This webinar is gone, but join our community to access recordings and slides. Go on the webinar page. For...
The European Independent Foundation in Angiology/Vascular: Guidance for patient management during the COVID-19 emergency
The European Independent Foundation in Angiology/Vascular Medicine is a non-profit, scientific foundation dedicated to...
Webinar: The Management of Cancer-Associated Thrombosis – Are we at a Crossroad?
This webinar is gone, but join our community to access recordings and slides. Go on the webinar page....
ISTH 2020 CONGRESS: CANCER-ASSOCIATED THROMBOSIS ABSTRACT OVERVIEW
The recent International Society on Thrombosis and Haemostasis (ISTH) Congress, held on 12–14 July 2020, as a virtual...
ARTET FOUNDATION PARTNERSHIP
ICTHIC Magazine is glad to announce the new partnership with ARTET foundation. ARTET (Association for the Research in...
PATIENTS’ EXPERIENCE OF LIVING WITH CANCER-ASSOCIATED THROMBOSIS: THE PELICAN PROJECT
The clinical issues and the main consequences of venous thromboembolism (VTE) in patients with cancer are nowadays well...